Type II collagen degradation and its regulation in articular cartilage in osteoarthritis

被引:229
作者
Poole, AR [1 ]
Kobayashi, M
Yasuda, T
Laverty, S
Mwale, F
Kojima, T
Sakai, T
Wahl, C
El-Maadawy, S
Webb, G
Tchetina, E
Wu, W
机构
[1] McGill Univ, Shriners Hosp Children, Dept Surg, Montreal, PQ, Canada
[2] McGill Univ, Shriners Hosp Children, Dept Med, Montreal, PQ, Canada
[3] Kyoto Univ, Sch Med, Dept Orthopaed Surg, Kyoto 606, Japan
[4] Univ Montreal, Fac Med Vet, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada
[5] Jewish Gen Hosp, Dept Orthopaed Surg, Montreal, PQ, Canada
[6] Nagoya Univ, Sch Med, Dept Orthopaed Surg, Nagoya, Aichi, Japan
[7] Glaxo Wellcome Res & Dev Ltd, Mol Cell Biol Unit, Stevenage SG1 2NY, Herts, England
[8] Massachusetts Gen Hosp, Arthrit Unit, Boston, MA 02114 USA
关键词
D O I
10.1136/ard.61.suppl_2.ii78
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:78 / 81
页数:4
相关论文
共 42 条
[1]   Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type IIIL-1 decoy receptor - Potential for pharmacological intervention [J].
Attur, MG ;
Dave, M ;
Cipolletta, C ;
Kang, P ;
Goldring, MB ;
Patel, IR ;
Abramson, SB ;
Amin, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40307-40315
[2]  
AURICH M, IN PRESS ARTHRITIS R
[3]   Gd-DTPA(2-) as a measure of cartilage degradation [J].
Bashir, A ;
Gray, ML ;
Burstein, D .
MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (05) :665-673
[4]   Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage [J].
Billinghurst, RC ;
Dahlberg, L ;
Ionescu, M ;
Reiner, A ;
Bourne, R ;
Rorabeck, C ;
Mitchell, P ;
Hambor, J ;
Diekmann, O ;
Tschesche, H ;
Chen, J ;
VanWart, H ;
Poole, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1534-1545
[5]  
Dahlberg L, 2000, ARTHRITIS RHEUM, V43, P673, DOI 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO
[6]  
2-8
[7]  
GARNERO P, IN PRESS ARTHRITIS R
[8]  
GOLDRING MB, 2002, ARTHRITIS RHEUM, V43, P1916
[9]  
Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO
[10]  
2-A